Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue

We aimed to describe the functional changes of Sertoli cells, based on the measurement of serum anti-Müllerian hormone (AMH) and inhibin B during treatment with GnRHa and after its withdrawal in boys with central precocious puberty. Six boys aged 0.8 to 5.5 yr were included. AMH was low at diagnosis...

Full description

Saved in:
Bibliographic Details
Main Authors: Romina P. Grinspon, Luz Andreone, Patricia Bedecarrás, María Gabriela Ropelato, Rodolfo A. Rey, Stella M. Campo, Ignacio Bergadá
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2013/823064
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832550683484618752
author Romina P. Grinspon
Luz Andreone
Patricia Bedecarrás
María Gabriela Ropelato
Rodolfo A. Rey
Stella M. Campo
Ignacio Bergadá
author_facet Romina P. Grinspon
Luz Andreone
Patricia Bedecarrás
María Gabriela Ropelato
Rodolfo A. Rey
Stella M. Campo
Ignacio Bergadá
author_sort Romina P. Grinspon
collection DOAJ
description We aimed to describe the functional changes of Sertoli cells, based on the measurement of serum anti-Müllerian hormone (AMH) and inhibin B during treatment with GnRHa and after its withdrawal in boys with central precocious puberty. Six boys aged 0.8 to 5.5 yr were included. AMH was low at diagnosis in patients >1 yr but within the normal range in younger patients. AMH increased to normal prepubertal levels during treatment. After GnRHa withdrawal, AMH declined concomitantly with the rise in serum testosterone. At diagnosis, inhibin B was elevated and decreased throughout therapy, remaining in the upper normal prepubertal range. In patients with testicular volume above 4 mL AMH remained higher in spite of suppressed FSH. After treatment withdrawal, inhibin B rose towards normal pubertal levels. In conclusion, AMH did not decrease in patients <1 yr reflecting the lack of androgen receptor expression in Sertoli cells in early infancy. Serum inhibin B might result from the contribution of two sources: the mass of Sertoli cells and the stimulation exerted by FSH. Sertoli cell markers might provide additional tools for the diagnosis and treatment followup of boys with central precocious puberty.
format Article
id doaj-art-2d61ea07b0be4ee5930d4d8e0948520b
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-2d61ea07b0be4ee5930d4d8e0948520b2025-02-03T06:06:07ZengWileyInternational Journal of Endocrinology1687-83371687-83452013-01-01201310.1155/2013/823064823064Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH AnalogueRomina P. Grinspon0Luz Andreone1Patricia Bedecarrás2María Gabriela Ropelato3Rodolfo A. Rey4Stella M. Campo5Ignacio Bergadá6Centro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, ArgentinaCentro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, ArgentinaCentro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, ArgentinaCentro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, ArgentinaCentro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, ArgentinaCentro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, ArgentinaCentro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE), CONICET-FEI-División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, C1425EFD Buenos Aires, ArgentinaWe aimed to describe the functional changes of Sertoli cells, based on the measurement of serum anti-Müllerian hormone (AMH) and inhibin B during treatment with GnRHa and after its withdrawal in boys with central precocious puberty. Six boys aged 0.8 to 5.5 yr were included. AMH was low at diagnosis in patients >1 yr but within the normal range in younger patients. AMH increased to normal prepubertal levels during treatment. After GnRHa withdrawal, AMH declined concomitantly with the rise in serum testosterone. At diagnosis, inhibin B was elevated and decreased throughout therapy, remaining in the upper normal prepubertal range. In patients with testicular volume above 4 mL AMH remained higher in spite of suppressed FSH. After treatment withdrawal, inhibin B rose towards normal pubertal levels. In conclusion, AMH did not decrease in patients <1 yr reflecting the lack of androgen receptor expression in Sertoli cells in early infancy. Serum inhibin B might result from the contribution of two sources: the mass of Sertoli cells and the stimulation exerted by FSH. Sertoli cell markers might provide additional tools for the diagnosis and treatment followup of boys with central precocious puberty.http://dx.doi.org/10.1155/2013/823064
spellingShingle Romina P. Grinspon
Luz Andreone
Patricia Bedecarrás
María Gabriela Ropelato
Rodolfo A. Rey
Stella M. Campo
Ignacio Bergadá
Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
International Journal of Endocrinology
title Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
title_full Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
title_fullStr Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
title_full_unstemmed Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
title_short Male Central Precocious Puberty: Serum Profile of Anti-Müllerian Hormone and Inhibin B before, during, and after Treatment with GnRH Analogue
title_sort male central precocious puberty serum profile of anti mullerian hormone and inhibin b before during and after treatment with gnrh analogue
url http://dx.doi.org/10.1155/2013/823064
work_keys_str_mv AT rominapgrinspon malecentralprecociouspubertyserumprofileofantimullerianhormoneandinhibinbbeforeduringandaftertreatmentwithgnrhanalogue
AT luzandreone malecentralprecociouspubertyserumprofileofantimullerianhormoneandinhibinbbeforeduringandaftertreatmentwithgnrhanalogue
AT patriciabedecarras malecentralprecociouspubertyserumprofileofantimullerianhormoneandinhibinbbeforeduringandaftertreatmentwithgnrhanalogue
AT mariagabrielaropelato malecentralprecociouspubertyserumprofileofantimullerianhormoneandinhibinbbeforeduringandaftertreatmentwithgnrhanalogue
AT rodolfoarey malecentralprecociouspubertyserumprofileofantimullerianhormoneandinhibinbbeforeduringandaftertreatmentwithgnrhanalogue
AT stellamcampo malecentralprecociouspubertyserumprofileofantimullerianhormoneandinhibinbbeforeduringandaftertreatmentwithgnrhanalogue
AT ignaciobergada malecentralprecociouspubertyserumprofileofantimullerianhormoneandinhibinbbeforeduringandaftertreatmentwithgnrhanalogue